The Motley Fool

Key Data Points

Primary metrics and data points about Hyperion Therapeutics.
Current Price: $45.97
Prev Close: $46.08
Open: $46.05
Bid: $0.00
Ask: $46.09
Day's Range: $45.96 - $46.09
52wk Range: $20.23 - $46.96
Volume: 96,553
Avg Vol 929,817
Market Cap: $955M
P/E (ttm): -148.65
EPS (ttm): ($0.31)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Hyperion Therapeutics from

Business Summary

Industry, sector and description for Hyperion Therapeutics.

Hyperion Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

HPTX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Hyperion Therapeutics.
CAPS Rating 2 out of 5
17 Outperform
18 Underperform
CAPS All Stars
7 Outperform
8 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Donald J. Santel, CEO

57% Approve

Based on 7 Ratings

Powered by

More Details about Hyperion Therapeutics

Primary metrics and data points about Hyperion Therapeutics.